Milestone Pharmaceuticals Inc.
MIST · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Giles Lisa M.: Form 4
Insider disclosure · Filed · Report period 10 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- MIST · 59935V107 - Common Shares, no par value
Company details and SEC sources
CIK 0001408443 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- MIST on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1111 Boul. Dr. Frederik Philips, Ste 420, Montreal, Quebec, Canada, H4M 2X6
- Incorporated in
- Quebec, Canada
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields